Saatci O et al. demonstrated that hypoxia triggers an increase in LOX expression via HIF-1α, subsequently activating integrin signalling and leading to decreased survival rates and resistance to chemotherapy in patients with triple-negative breast cancer (TNBC) 43. Here, LOX is linked to triple-negative breast carcinoma.